IRCT20201203049585N2
Recruiting
未知
Comparative study of the effectiveness of low-dose lung radiation in comparison with placebo in the treatment of cancer patients with severe inflammatory phase of covid19 pneumonia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Covid-19 Pneumonia.
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 36
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Over 18 years
- •Having cancer
- •Covid\-19 pneumonia that has been confirmed by PCR test
- •Lung involvement more than 50% that has been confirmed by HRCT
- •Interleukin\-6 \= 40 or establishing two of the following criteria: D\-dimmer \= 1000 CRP \= 100 LDH \= 300 Ferritin \= 500
- •Not a candidate for ICU admission
Exclusion Criteria
- •Any contraindication for radiotherapy
- •Current chest radiotherapy
- •Active pulmonary metastasis
- •A history of previous lung radiotherapy
- •Being pregnant
- •The patient's WBC be less than 1000 in the day before the intervention
- •Unable to understand the conditions of the intervention, in the terms of mental health
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Comparison of administration of low dose ketamine with lidocaine on changes in heart rate and blood pressure during intubatioCandidate patients for surgery under general anesthesia.IRCT20200825048515N56Esfahan University of Medical Sciences90
Completed
Phase 2
Efficacy of oral low-dose Isotretinoin in the treatment of acne vulgarisAcne vulgaris.Acne vulgarisIRCT2015061722780N1Vice chancellor for research of Isfahan University of Medical Sciences60
Completed
Not Applicable
Enoxaparin in treatment of lichen planuslichen planus.lichen planus tropicusIRCT2012122211841N1Vice chancellor for Administrative and Financial of Medical School46
Completed
Not Applicable
Evaluation of the safety and efficacy of low dose transgenic rice containing peptides from Japanese cedar pollen allergens.JPRN-UMIN000016078The Jikei University, School of Medicine21
Active, not recruiting
Not Applicable
ow doses of Rituximab in Graves orbitopathyActive moderate to severe Graves OrbitopathyMedDRA version: 14.1Level: PTClassification code 10060742Term: Endocrine ophthalmopathySystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Hormonal diseases [C19]EUCTR2012-001980-53-ITFONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO10